Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Gene Therapy00:59

Gene Therapy

25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
What is Genetic Engineering?00:49

What is Genetic Engineering?

74.0K
Overview
74.0K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Harmonizing standards and resources for the medical genome.

Nature·2026
Same author

Enhancing STEMM Education Through Advanced Technologies and Collaborative Programs.

Journal of biomolecular techniques : JBT·2025
Same author

Novel humanized loss-of-function NF1 mouse model of juvenile myelomonocytic leukemia.

Blood advances·2025
Same author

Opportunities and Challenges With CAR T-cell Treatment of Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia: Review and Recommendations From the Westhafen Intercontinental Group.

Transplantation and cellular therapy·2025
Same author

Conquering the gene and cell therapy viability crisis: A path paved by ASGCT.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Clearing the hurdles for CAR-T cell treatment.

Nature reviews. Immunology·2025
Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026
Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026
Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026
Same journal

Retraction.

Science (New York, N.Y.)·2026
Same journal

Making time.

Science (New York, N.Y.)·2026
查看所有相关文章

相关实验视频

Updated: Jun 18, 2025

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

509

细胞和基因疗法的可用性

Rayne H Rouce1, Matthew H Porteus2

  • 1Rayne H. Rouce is an associate professor at the Center for Cell and Gene Therapy, Dan L. Duncan Comprehensive Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.

Science (New York, N.Y.)
|August 1, 2024
PubMed
概括
此摘要是机器生成的。

创新的细胞和基因疗法 (CGTs) 为严重疾病提供改变生活的治疗方法. 然而,对于许多需要这些先进的医疗干预的患者来说,它们的高成本构成了可获得性障碍.

更多相关视频

Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications
03:52

Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications

Published on: February 9, 2024

2.5K
Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.6K

相关实验视频

Last Updated: Jun 18, 2025

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

509
Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications
03:52

Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications

Published on: February 9, 2024

2.5K
Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.6K

科学领域:

  • 生物技术
  • 遗传学
  • 癌症学
  • 血液学
  • 神经学

背景情况:

  • 细胞和基因疗法在治疗严重疾病方面取得了重大进展.
  • 这些创新疗法对包括癌症,状细胞疾病和神经系统疾病在内的疾病有很大的前景.

研究的目的:

  • 突出CGT在解决以前无法治疗的疾病方面的变革潜力.
  • 确定和解决这些先进疗法的高成本和有限可用性的关键障碍.

主要方法:

  • 本分析综合了目前对CGT发展和临床影响的理解.
  • 它研究了经济因素,特别是CGT的高价格区间 (每剂30万美元至400万美元).
  • 这项研究回顾了多方利益相关者合作应对可访问性挑战的必要性.

主要成果:

  • 对于患有严重疾病的患者来说,
  • 综合医疗服务的高昂成本阻碍了患者广泛使用该服务.
  • 目前的定价模式可能会阻止许多符合条件的患者接受这些潜在的治疗方法.

结论:

  • 实现对改变生命的细胞和基因疗法的公平获得需要学术界,工业界,投资者,资助者,监管机构和患者倡导团体的共同努力.
  • 协作策略是必不可少的, 让所有可以受益的患者能够获得CGT的突破.
  • 应对经济挑战对于充分发挥CGT在公共卫生方面的潜力至关重要.